“The Phase 1 clinical trial is designed to evaluate the safety, reactogenicity, and immunogenicity of ARCT-2304 as a potential vaccine to protect against the highly pathogenic H5N1 avian influenza .
A 2023 avian flu outbreak decimated a Caspian tern colony on Rat Island and spread to harbor seals, posing a new threat to local wildlife. A 2023 epidemiological study revealed that 56% of a large ...
USDA will begin bulk testing milk supplies starting in states where dairy cattle tested positive last spring for the H5N1 bird flu virus. Bird flu is an increasing concern for USDA, amid H5N1 infectio ...
Some results have been hidden because they may be inaccessible to you